Your search returned 5 results.

Results
	1.	HLA-DR and HLA-DP restricted epitopes from human cytomegalovirus glycoprotein B recognized by CD4+ T-cell clones from chronically infected individuals. [electronic resource] by Ventura, Claire Bisceglia, Hélène Girerd-Chambaz, Yves Burdin, Nicolas Chaux, Pascal Producer: 20130524 In: Journal of clinical immunology vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein. [electronic resource] by Zhang, Yi Chaux, Pascal Stroobant, Vincent Eggermont, Alexander M M Corthals, Jurgen Maillère, Bernard Thielemans, Kris Marchand, Marie Boon, Thierry Van Der Bruggen, Pierre Producer: 20030922 In: Journal of immunology (Baltimore, Md. : 1950) vol. 171 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Tumor-specific shared antigenic peptides recognized by human T cells. [electronic resource] by Van Der Bruggen, Pierre Zhang, Yi Chaux, Pascal Stroobant, Vincent Panichelli, Christophe Schultz, Erwin S Chapiro, Jacques Van Den Eynde, Benoît J Brasseur, Francis Boon, Thierry Producer: 20030616 In: Immunological reviews vol. 188 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	CD4+ T-cell clones specific for wild-type factor VIII: a molecular mechanism responsible for a higher incidence of inhibitor formation in mild/moderate hemophilia A. [electronic resource] by Jacquemin, Marc Vantomme, Valérie Buhot, Cécile Lavend'homme, Renaud Burny, Wivine Demotte, Nathalie Chaux, Pascal Peerlinck, Kathelijne Vermylen, Jos Maillere, Bernard van der Bruggen, Pierre Saint-Remy, Jean-Marie Producer: 20030313 In: Blood vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models. [electronic resource] by Larsson, Pär G Lakshmikanth, Tadepally Laitinen, Olli H Utorova, Renata Jacobson, Stella Oikarinen, Maarit Domsgen, Erna Koivunen, Minni R L Chaux, Pascal Devard, Nicolas Lecouturier, Valerie Almond, Jeffrey Knip, Mikael Hyöty, Heikki Flodström-Tullberg, Malin Producer: 20150921 In: Diabetologia vol. 58 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)